FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Dr Reddys Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500124 P/E (TTM) :23.37
ISIN Demat:INE089A01031 Div & Yield %:0.62 EPS (TTM) :55.59
Book Value (RS) :377.55276 Market Cap (Rs Cr.):108417.29 Face Value (RS) :1
    Change Company 
Particulars Quarter Ended
(Dec 2025)		 Quarter Ended
(Dec 2024)		 Quarter Ended
(% Var)
Sales 4,266.40 4,997.80 -14.63
Other Income 360.30 235.40 53.06
PBIDT 459.90 1,427.80 -67.79
Interest 41.40 43.30 -4.39
PBDT 418.50 1,384.50 -69.77
Depreciation 314.30 265.10 18.56
PBT 104.20 1,119.40 -90.69
Tax 13.00 256.30 -94.93
Deferred Tax 0.60 13.70 -95.62
PAT 90.60 849.40 -89.33

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)